Nursing researcher receives over $500K in prestigious grants

Oct 14, 2025

3 min

Blake McGee, PhD, MPH, RN

For the first time in nearly 15 years, a faculty member from Augusta University’s College of Nursing has been awarded a grant from the National Institutes of Health.


Blake McGee, PhD, has secured an R03 award of $176,331 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study Medicaid’s expanded role in late postpartum maternal health.


But he hasn’t stopped there as McGee is also part of the fifth cohort of Betty Irene Moore Fellows, a prestigious program for nurse leaders and innovators that has awarded CON half a million dollars to support his research project and leadership development.


McGee, the prelicensure department chair and an associate professor, is collaborating with colleagues from other Georgia universities on both studies, which are occurring simultaneously.





“I began my career as an ER nurse and have always wanted to ask bigger questions about the challenges facing patients and how we might best address them as a society,” said McGee, who was recently selected for publication in Blood Advances, the American Society of Hematology’s journal. “As nursing scientists, we are uniquely poised to ask questions about healthcare policy, specifically from the vantage point of the impact that policy choices have on patients and their health outcomes.”





This century, the United States has seen rising maternal mortality rates with alarming racial disparities. Over half of these deaths occur in the postpartum period, with 23% occurring more than six weeks after delivery. Medicaid expansion covers pregnant women in households below 138% of the Federal poverty level through postpartum day 60, which has been associated with decreased mortality and reduced racial disparity in maternal death.


At the time of grant submission, pregnancy Medicaid eligibility traditionally lapsed 60 days after delivery, leaving postpartum people vulnerable to disruptions in care. McGee’s work aims to identify changes in maternal health care use and health outcomes 60 days to 1 year after delivery that were associated with state Medicaid expansions (2007–19).


The team will examine whether the effects of expansion vary by maternal race or ethnicity and will explore whether patient-reported health care access and quality mediate the relationships between expansion and outcomes.


“My hope is that after the study we’ll have a better understanding of how health and health care use change for women in this crucial late postpartum period and how they may differ for people of different backgrounds,” said McGee. “Due to the sample design, findings will reliably inform optimal policy for postpartum coverage duration.”


He expects this study to provide preliminary data for a future R01-funded study that directly examines the impact of extending the duration of postpartum Medicaid under the American Rescue Plan.



As part of the Betty Irene Moore Fellowship, McGee is one of 15 fellows across the nation in a curriculum co-delivered by the UC Davis School of Nursing and Graduate School of Management. A project coordinator from AU’s School of Public Health will also assist with the fellowship project. McGee hopes to involve graduate research assistants or recent alumni as research associates on the team.



Specifically, McGee will be studying the Georgia Pathways to Coverage Program, making him one of the only academic researchers in the nation funded to do so.


“As a researcher, it is always a privilege to engage in topics that directly impact the current state of health care, and I’m honored to tackle projects that are so relevant to today’s health policy headlines,” he said.


Georgia stands out among other states that are exploring an extension of Medicaid to low-income, working-age adults who demonstrate a monthly commitment of 80 hours to an employment-related activity. By studying the effects of this program, McGee predicts the findings will be highly relevant to anticipating the impact of recent Medicaid changes at the federal level and may indicate differences between Pathways participants and those who might qualify but remain uninsured. This focus could provide data that helps the state target enrollment efforts. The state’s own logic model predicts that the program will reduce hospitalizations, and McGee is eager to determine the program’s success.


“Our findings should be helpful to the state to better understand those enrolling, what their experience with increased access to care has been and how their health has improved after receiving coverage,” McGee said.
Connect with:
Blake McGee, PhD, MPH, RN

Blake McGee, PhD, MPH, RN

Associate Professor

Blake McGee studies the impacts of federal and state policy choices on economically or socially marginalized people.

Affordable Care ActMedicareHealth PolicyMedicaidEmergency Nursing‎
Powered by

You might also like...

Check out some other posts from Augusta University

When Science Can't Be Repeated: Tackling a Crisis in Research featured image

3 min

When Science Can't Be Repeated: Tackling a Crisis in Research

Science depends on a simple but critical principle: Research findings should be reliable enough that other researchers can reproduce them. But what happens when they can't? Biomedical research is confronting what has become known as the “reproducibility crisis,” with major scientific journals estimating that more than 80% of published biomedical research is negatively affected by defects that can make findings non-reproducible or unusable. Now, researchers at Augusta University are taking a closer look at why research goes wrong – and, more importantly, whether those problems can be prevented before findings are published. Backed by a new $2.5 million R01 grant from the National Institutes of Health, researchers in Augusta University's School of Public Health will identify common research defects and develop strategies to help scientists avoid them. The project is led by E. Andrew Balas, MD, PhD, a professor in the Department of Health Management, Economics, and Policy who has spent more than a decade studying the research process itself. “Research quality is not only a matter of detecting errors after they occur. The critical question is, how can we understand the conditions that produce research defects and develop effective ways to prevent them before they compromise scientific results?”  E. Andrew Balas, MD, PhD The consequences extend well beyond the laboratory. Unreliable findings can influence patient care, waste research funding and send other scientists down paths built on results that were never dependable. They can also contribute to something increasingly important for the scientific community: declining public trust. The Augusta University team plans to create a database of common research defects and examine which stages of the research process are particularly vulnerable. Researchers also envision a tool that could eventually allow scientists to enter information about their methodology and identify potential problems before completing and publishing their work. Wendy Burnett, PhD, an assistant professor in the School of Public Health and co-investigator on the study, summed up the stakes: “Years of work and substantial funding may be invested in studies based on results that were never dependable.”  Wendy Burnett, PhD The interdisciplinary project will also examine the human side of the problem, gathering perspectives from researchers, peer reviewers and journal editors to better understand why research defects happen and what may prevent people from recognizing or addressing them. Ultimately, the research asks a question that goes to the heart of modern science: How can we make research more trustworthy before mistakes become part of the scientific record? After the project is complete, Balas and his team hope the results will ultimately impact science and society in many significant ways. “Research has made wonders in our lives – we have life-saving drugs, we have a lifestyle that is healthier than ever before and so forth. If research could produce more valuable, useful, trustworthy, reproducible results, then we will all be better, and it should also increase public trust in research.” For media covering scientific integrity, biomedical research, public trust in science, research funding, peer review or the reproducibility crisis, this work offers a timely look at how the scientific community can improve not only what it discovers, but how those discoveries are made.

AU Hosts Congressional Hearing on 'Building an AI-Ready America' featured image

3 min

AU Hosts Congressional Hearing on 'Building an AI-Ready America'

The U.S. House Committee on Education and Workforce held its first artificial intelligence field hearing of the year, titled "Building an AI-Ready America: How AI Is Creating Opportunities Across America's Workforce," at the Georgia Cyber Center at Augusta University on July 24. U.S. Rep. Rick W. Allen, who represents Georgia's 12th District and chairs the committee's Subcommittee on Health, Employment, Labor, and Pensions, chaired the hearing. He was joined by U.S. Rep. Joe Wilson of South Carolina and U.S. Rep. Lucy McBath of Georgia. Jeffery Talbert, PhD, chair of Augusta University's Department of Artificial Intelligence and Health at the Medical College of Georgia and a Georgia Research Alliance Eminent Scholar, served as one of four witnesses at the hearing. "Today, we examine how artificial intelligence, AI, is creating economic opportunities for American workers, job creators and our communities," Allen told the committee. "There's no better place to hold this hearing than right here in Augusta." Allen said the combination of the Georgia Cyber Center and Fort Gordon provides the expertise needed to discuss AI. "Fort Gordon is just a short 30-minute drive from where we currently sit," he said. "It hosts the Army Cyber Center of Excellence and is home to Army Cyber School, which trains, educates and develops the Army's Cyberspace and Electronic Warfare workforce. Every year, thousands of people leave Fort Gordon looking for work." He added that the Georgia Cyber Center "was created to meet this growing demand and drive collaboration between academia, government and industry stakeholders to equip a superior cybersecurity workforce with the skills they need." Augusta University President Russell T. Keen told the committee it was an honor for AU's Georgia Cyber Center to host the hearing. "Congressman Allen has long recognized the important role that education, innovation and workforce development play in strengthening our state and our nation," Keen said. He added that AI "will continue to change how we live, how we learn, how we work and how we solve problems," and that Augusta University "intends to lead in that transformation in ways that strengthen our workforce, advance discovery, improve lives, change lives and save lives." Talbert, who has more than 30 years of experience in biomedical informatics, has published approximately 260 times and has led more than 100 funded research projects totaling more than $130 million. He told the committee that in health care, AI is demonstrating its greatest value through augmentation, helping professionals "work more effectively, reducing administrative burdens, improving patient outcomes and expanding workforce capacity." He pointed to ambient documentation technology, which converts clinical conversations into draft notes clinicians review and approve, as one of the industry's most successful AI applications. "Multiple studies show these tools reduce documentation burden, after-hours work and burnout," Talbert said. "One multisystem implementation found clinician burnout fell from approximately 52 percent to 39 percent." He also cited studies showing AI-assisted breast cancer screening detecting approximately 29 percent higher cancer rates, "helping more patients benefit from earlier diagnosis and treatment." America's opportunity, Talbert said, "is not simply to adopt AI, but to lead its responsible development, education and implementation." He pointed to Augusta University's Department of AI and Health, the first of its kind in Georgia, as an example of that approach. Allen closed the hearing by cautioning against a one-size-fits-all approach to AI policy. "The needs of a family farm are not the same as those of a hospital, a manufacturing plant or a small business," he said. "Congress must pursue flexible policies that allow businesses to adopt AI in ways that best suit their industry and workforce." JagWire has the full recap of the hearing and the Augusta Chronicle, Innovation & Entrepreneurs News and Traders Union also covered the field hearing. Augusta University experts in artificial intelligence, healthcare innovation and workforce development are available for interviews. If you're covering similar stories, reach out to schedule time.

MCG researchers awarded $275K grant to study HIV and retinopathy correlation featured image

3 min

MCG researchers awarded $275K grant to study HIV and retinopathy correlation

It’s often said that “teamwork makes the dream work,” and scientists from different disciplines at Augusta University are a perfect example of that. Manuela Bartoli, PhD, research director and professor of ophthalmology at AU’s Medical College of Georgia, has joined forces with Eric Belin de Chantemèle, PhD, a physiologist in MCG’s Vascular Biology Center, to explore the link between HIV and retinopathy. The pair was recently awarded a two-year $275,000 grant from the National Eye Institute that will allow them to test different variables on a transgenic mouse model and assess how they impact the development of retinopathy. The project began with Bartoli and Belin de Chantemèle examining transgenic mice that expressed viral proteins linked to HIV. They found that the blood vessels supplying oxygen and nutrients to the mice’s retinas were not functioning properly. “So, we developed the idea that people living with HIV may be more prone to or progress more rapidly when they get one of the ischemic retinopathies that are very common, particularly diabetic retinopathy and age-related macular degeneration,” Bartoli said. “I think this is important because we’ll basically define a chronic HIV infection as a risk factor for the development of the most severe ocular disease.” Bartoli’s work focuses on ischemic retinopathies, which are conditions that reduce blood flow, oxygen and nutrients to the retina – the part of the eye responsible for vision. These disorders are the leading cause of blindness around the world. Different types include retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration. Several factors contribute to ischemic retinopathies, such as oxidative stress and inflammatory processes. Bartoli infers HIV might be another risk factor, but it’s tough to confirm as antiretroviral therapies make the virus nearly undetectable. “The number of people living with HIV is growing in terms of age, so most likely they will develop, at some point, a disease like age-related macular degeneration, which is really common in the elderly population,” Bartoli said. “We knew the individual has the acute infection, and because of the immunosuppression, they develop a number of infections that lead to retinal dysfunction. There was also reported what is called retinitis due to HIV. But with medication, these acute events disappear, and we don’t know, when you get older and develop one of these diseases, how is it going to progress?” While cART therapies can manage HIV, Bartoli noted they don’t fix the defective blood vessels in the retina. And it’s not just the retina. The big picture is that HIV alters blood vessels throughout the human body, therefore elevating blood pressure and causing cardiovascular disease. “We have blood vessels in every single organ, whether this is the heart, the lungs, the kidneys, the brain, the eyes, they are everywhere,” Belin de Chantemèle said. “As HIV is damaging the vessel, that would lead to dysfunctions in all those different organs.” “On top of that, people who have HIV usually have additional comorbidities. Very often people become obese, have diabetes,” he continued. The researchers plan to eventually move beyond mouse models and include human subjects in their study. “I’m already working with people around to try to get information,” Bartoli said. “For example, in the VA system.” The ultimate goal is to establish how HIV contributes to the progression of eye diseases, which will hopefully lead to a better understanding of why it happens and how to treat it. “If this individual who progresses more rapidly goes to the doctor when they are blind already or semi-blind, it’s too late for anything,” Bartoli said. “Blindness is the primary fear in people, so we’re going to combat the cause to prevent this side effect.” Discoveries at Augusta University are changing and improving the lives of people in Georgia and beyond. Your partnership and support are invaluable as we work to expand our impact. See more experts at Augusta University → Click here

View all posts